Beta Cell Therapy Translational Programme Grants

The Beta Cell Therapy Grand Challenge will support research focused on the development of approaches that will restore beta cell function in people living with type 1 diabetes.

Amount: Applications led by an individual clinical or non-clinical group leaders: up to £1.5M; Applications jointly led by up to three group leaders: £2-3M

Duration: 3-5 years

Skills: Multidisciplinary

Location: UK and European Researchers – Principal Applicant must be based in the UK

Process: 2-stages – 1) Expression of interest; If shortlisted : 2) Full Application and Interview

Expression of Interest Deadline: 28 April 2023; Full Application Deadline : 14 August 2023 and Interviews : w/c 2 October 2023

This call is focused on translation. This is designed to provide the injection of funds needed to fast-track burgeoning beta cell ideas towards the clinic.

Applications submitted under this call should focus on beta cell replacement and regeneration for the treatment of type 1 diabetes. The Beta Cell Therapy Scientific Advisory Panel has identified two themes to be addressed by this call.